Dare Bioscience
DARE1.18510.23% ( -0.135 )
Dare Bioscience (DARE)
Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in...
- Open
- 1.310
- High
- 1.310
- Low
- 1.180
- Prev. Close
- 1.320
- Volume
- 169.48K
- Turnover
- 210.04K
- Avg Price
- 1.239
- Bid/Ask Ratio
- --
- Amplitude
- 9.85%
- 52wk High
- 3.780
- Volume Ratio
- 0.61
- Turnover Ratio
- 1.23%
Dare Bioscience Analyst Rating
View MoreForecast & Rating
May 18, 2026Price forecast
$9.67715.75%
Forecast & RatingStrong buy
3analysts
- Strong buy66.67%
- Buy33.33%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Baystreet · 14 hours ago
Dare Slides on MyMenopauseRx Hookup
- Unusual Whales · 17 hours ago
Daré Bioscience Expands Access Options for DARE to PLAY™ and Specialized Menopause Care Through Strategic Collaboration with MyMenopauseRx
- Tip Ranks · Jul 24 at 08:29 AM
Daré Bioscience Releases New Investor Corporate Presentation
- benzinga_article · Jul 20 at 12:05 PM
12 Health Care Stocks Moving In Monday's Intraday Session
- Tip Ranks · Jul 17 at 04:32 PM
Daré Bioscience Faces Nasdaq Listing Compliance Challenges
- Tip Ranks · Jul 13 at 12:25 PM
Daré Bioscience Updates Investors With New Presentation
